A Study to Evaluate the Safety, Efficacy, and Pharmacodynamics of PLL001 in ALS Patients
Clinical trial NCT06513546 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06513546
- Sponsor
- PLL TX AUSTRALIA PTY LTD
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-08
- Primary completion
- 2026-12-15
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.